| 13-Jun-13 08:30PM | Oculus Innovative Sciences Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 04:05PM | Oculus Innovative Sciences Reports Revenues of $15.5 Million for Fiscal Year 2013, Product Revenue Up 23 Percent GlobeNewswire |
| 09:39AM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 07:07AM | Q4 2013 OCULUS INNOVATIVE SCIENCES INC Earnings Release - After Market Close CCBN |
| 11-Jun-13 01:00PM | 5 Hated Earnings Stocks That Deserve Your Love at TheStreet |
| 07-Jun-13 10:01AM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors EDGAR Online |
| 06-Jun-13 08:10AM | InPlay: Oculus Innovative Sciences enters into two key agreements, which establish the license and supply as well as shared services with its subsidiary, Ruthigen Briefing.com -5.38% |
| 08:08AM | Oculus Innovative Sciences Announces Two Key Agreements With Company's Subsidiary, Ruthigen, Inc. GlobeNewswire |
| 05-Jun-13 07:30AM | [video] Can Virtual Reality Make You a Better Person? at MarketWatch |
| 30-May-13 03:51AM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online |
| 29-May-13 01:00AM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online -14.04% |
| 28-May-13 08:12AM | InPlay: Oculus Innovative Sciences announces confidential submission of draft registration statement for IPO to SEC by its subsidiary Ruthigen Briefing.com |
| 08:08AM | Oculus Announces Confidential Submission of Draft Registration Statement for Initial Public Offering to Securities and Exchange Commission by Its Subsidiary Ruthigen, Inc. GlobeNewswire |
| 23-May-13 08:08AM | Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2013 Financial Results and Conference Call GlobeNewswire +5.58% |
| 17-May-13 11:07AM | Bypassing Biotechs and Focusing on the Overlooked Medical Device Space: An Expert Portfolio Manager Discusses His Contrarian Approach to Investing Wall Street Transcript +8.21% |
| 08-May-13 06:04PM | Nasdaq stocks posting largest percentage decreases AP -16.00% |
| 01:28PM | Nasdaq stocks posting largest percentage decreases AP |
| 07-May-13 06:02PM | Nasdaq stocks posting largest percentage decreases AP -14.53% |
| 01:55PM | Short On Oculus: Wound Care Company Has Left Dirty Scars at Seeking Alpha |
| 01-May-13 08:13AM | InPlay: Oculus Innovative Sciences announces new regulatory approvals for Microcyn-Based antiseptic products in Panama and El Salvador Briefing.com +6.46% |
| 08:08AM | Oculus Innovative Sciences Announces New Regulatory Approvals for Microcyn(R)-Based Antiseptic Products in Panama and El Salvador GlobeNewswire |
| 24-Apr-13 08:10AM | InPlay: Oculus Innovative Sciences announces new regulatory approvals and target launch dates for three new Microcyn-based products in Middle East countries Briefing.com |
| 08:08AM | Oculus Innovative Sciences Announces New Regulatory Approvals and Target Launch Dates for Three New Microcyn(R)-Based Products in Middle East Countries GlobeNewswire |
| 19-Apr-13 08:00AM | Align's Earnings Beat Ests, Revs Grow Zacks +9.76% |
| 13-Apr-13 09:32AM | Wound Care Market: The Promise Of Healing at Seeking Alpha |
| 10-Apr-13 08:08AM | Oculus Innovative Sciences to Rollout Five New Microcyn(R) Technology-Based Products in Singapore and Malaysia GlobeNewswire |
| 08-Apr-13 11:03AM | Small Pharma Watch List: Week Of April 8, 2013 at Seeking Alpha |
| 04-Apr-13 08:11AM | Oculus issued three new international patents for Microcyn technology theflyonthewall.com |
| 08:10AM | InPlay: Oculus Innovative Sciences announces issuance of three new international patents for Microcyn technology Briefing.com |
| 08:08AM | Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of Three New International Patents for Microcyn(R) Technology GlobeNewswire |
| 01-Apr-13 03:28PM | Oculus And NovaBay: 100% Upside Potential at Seeking Alpha +9.42% |
| 11:45AM | David & Goliath: Small Biotechs Wage a Big Fight Against the Superbug at Minyanville |
| 01:20AM | InPlay: Oculus Innovative Sciences announces a 1-for-7 reverse split of its common stock will be effective at the open of business on Monday, April 1, 2013 Briefing.com |
| 28-Mar-13 08:21PM | Oculus Innovative Sciences Announces Reverse Split of Common Stock GlobeNewswire +10.00% |
| 26-Mar-13 08:08AM | Oculus Innovative Sciences Expands Regulatory Claims for Microcyn-Based Advanced Wound Management Products in Europe GlobeNewswire |
| 22-Mar-13 10:06AM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Article EDGAR Online |
| 20-Mar-13 08:08AM | Oculus Innovative Sciences Appoints Jerry McLaughlin to Its Board of Directors GlobeNewswire |
| 14-Mar-13 09:12AM | InPlay: Oculus Innovative Sciences announces completion of patient follow-up in scar Management study; co is encouraged by the initial clinical trial results from the management of scars trial Briefing.com |
| 08:08AM | Oculus Innovative Sciences Announces Completion of Patient Follow-Up in Scar Management Study GlobeNewswire |
| 13-Mar-13 02:41AM | InPlay: Oculus Innovative Sciences prices 8.625 mln common shares at $0.40 per share Briefing.com |
| 12-Mar-13 09:01PM | Oculus Innovative Sciences Announces Closing of Public Offering of 8,625,000 Shares of Common Stock GlobeNewswire |
| 07-Mar-13 05:20PM | Oculus Innovative Sciences, Inc. Announces Full Exercise of Underwriters' Over-Allotment Option GlobeNewswire -20.37% |
| 04:54PM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements EDGAR Online |
| 03:36PM | 4 Healthcare Stock Stories Not To Be Overlooked at Wall St. Cheat Sheet |
| 01:53PM | Thursdays movers: Facebook gains on new update at MarketWatch |
| 12:15PM | Thursdays movers: Apple recovers on U.K. win at MarketWatch |
| 11:46AM | Thursdays movers: Citi cuts Apple iPhone estimate at MarketWatch |
| 09:57AM | Thursdays movers: Icahn turns aggressive on Dell at MarketWatch |
| 08:16AM | Thursdays biggest gaining and declining stocks at MarketWatch |
| 12:22AM | Oculus Innovative Sciences Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock and Intention to Repay Certain Indebtedness GlobeNewswire |
| 06-Mar-13 04:02PM | InPlay: Oculus Innovative Sciences Announces Proposed Public Offering of Common Stock and Intention to Repay Certain Indebtedness; size of offering not disclosed Briefing.com -11.48% |
| 04:01PM | Oculus Innovative Sciences Announces Proposed Public Offering of Common Stock and Intention to Repay Certain Indebtedness GlobeNewswire |
| 25-Feb-13 08:14AM | InPlay: Oculus Innovative Sciences announces Issuance of U.S. patent for treatment of skin ulcers with Microcyn Technology Briefing.com -6.35% |
| 08:08AM | Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Treatment of Skin Ulcers With Microcyn(R) Technology GlobeNewswire |
| 21-Feb-13 01:04PM | OCULUS INNOVATIVE SCIENCES, INC. Financials EDGAR Online Financials -6.06% |
| 20-Feb-13 06:08PM | Nasdaq stocks posting largest volume increases AP |
| 19-Feb-13 06:07PM | Nasdaq stocks posting largest volume increases AP |
| 15-Feb-13 06:07PM | Nasdaq stocks posting largest volume increases AP |
| 14-Feb-13 03:17PM | 2 Fast Growing Wound Care Companies With Upcoming Milestones at Seeking Alpha |
| 09:17AM | New Star Analyst Rankings for Oculus Innovative Sciences, Inc StarMine |
| 06:20AM | Oculus Innovative Sciences Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 13-Feb-13 04:31PM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online |
| 04:05PM | Oculus Innovative Sciences Reports Revenues of $3.5 Million for the Third Quarter of Fiscal 2013 GlobeNewswire |
| 07:07AM | Q3 2013 OCULUS INNOVATIVE SCIENCES INC Earnings Release - After Market Close CCBN |
| 05-Feb-13 08:08AM | Ruthigen, Inc., Subsidiary of Oculus Innovative Sciences, Inc., Appoints Sameer Harish as Chief Financial Officer GlobeNewswire |
| 04-Feb-13 04:53PM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements EDGAR Online |
| 31-Jan-13 08:08AM | Oculus Innovative Sciences Announces Fiscal Third Quarter 2013 Financial Results and Conference Call GlobeNewswire |
| 28-Jan-13 08:17AM | InPlay: Oculus Innovative Sciences: Ruthigen establishes independent headquarters and targets public offering In 2013 Briefing.com |
| 08:08AM | Ruthigen Establishes Independent Headquarters and Targets Public Offering In 2013 GlobeNewswire |
| 11-Jan-13 06:02PM | Nasdaq stocks posting largest volume increases AP +6.49% |
| 10-Jan-13 06:03PM | Nasdaq stocks posting largest volume increases AP +13.24% |
| 08:30AM | InPlay from Briefing.com Briefing.com |
| 08:13AM | InPlay: Oculus Innovative Sciences announces plan to spin off biotechnology business Briefing.com |
| 08:08AM | Oculus Innovative Sciences, Inc. Announces Plan to Spin Off Biotechnology Business GlobeNewswire |
| 03-Jan-13 01:12PM | Vista Partners Publishes January 2013 Macroeconomic & Investment Newsletter Marketwire |
| 27-Dec-12 03:46PM | InterMune Insider Trading, Depomed Drops Lawsuits: Healthcare Business Update at Wall St. Cheat Sheet -14.75% |
| 08:08AM | InPlay: Oculus Innovative Sciences announces issuance of new U.S. patent for the use of Microcyn Technology in the treatment of skin ulcers Briefing.com |
| 08:08AM | Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Treatment of Skin Ulcers With Microcyn(R) Technology GlobeNewswire |
| 24-Dec-12 08:08AM | In Preparation for European Partnership, Oculus Innovative Sciences Expects Expanded Label Claim for European Formulation of Dermacyn(TM) Wound Care GlobeNewswire |
| 21-Dec-12 04:31PM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru EDGAR Online |
| 11-Dec-12 08:11AM | Oculus provides second half CY12 business update at theflyonthewall.com |
| 08:08AM | Oculus Innovative Sciences Provides Second Half CY 2012 Business Update GlobeNewswire |
| 04-Dec-12 09:00AM | Vista Partners Publishes December 2012 Newsletter Marketwire -10.14% |
| 28-Nov-12 07:13PM | Oculus Innovative Sciences' CEO Presents at New York City Financial Analysts Presentation (Transcript) at Seeking Alpha |
| 27-Nov-12 08:08AM | Oculus Innovative Sciences to Host New York City Financial Analysts Presentation on November 28, 2012 GlobeNewswire |
| 26-Nov-12 08:16AM | Oculus to create subsidiary for anti-infective drug assets theflyonthewall.com |
| 08:08AM | Oculus Innovative Sciences to Create Subsidiary for Company's Anti-Infective Drug Assets GlobeNewswire |
| 17-Nov-12 01:04PM | OCULUS INNOVATIVE SCIENCES, INC. Financials EDGAR Online Financials |
| 14-Nov-12 08:08AM | Oculus Innovative Sciences Completes Patient Enrollment in Study of Microcyn(R) Hydrogel in Management of Scars GlobeNewswire |
| 08-Nov-12 04:33PM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08:08AM | Oculus Innovative Sciences to Host New York City Financial Analysts Presentation on November 28, 2012 GlobeNewswire |
| 05-Nov-12 04:38PM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 08:13AM | InPlay: Oculus Innovative Sciences achieves net worth of $4.5 mln pro forma as of Sep 30, 2012 and regains compliance with the stockholders' requirement of the NASDAQ listing rules Briefing.com |
| 08:08AM | Oculus Innovative Sciences Achieves Net Worth of $4.5 Million Pro Forma as of September 30, 2012 and Regains Compliance with the Stockholders' Requirement of the NASDAQ Listing Rules GlobeNewswire |
| 04-Nov-12 09:34AM | New Star Analyst Rankings for Oculus Innovative Sciences, Inc StarMine |
| 02-Nov-12 09:40AM | New Star Analyst Rankings for Oculus Innovative Sciences, Inc StarMine |
| 08:08AM | Oculus Innovative Sciences to Reschedule New York City Financial Analysts Presentation Originally Scheduled for November 5th Due to Impact of Storm Sandy GlobeNewswire |
| 01-Nov-12 04:32PM | OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operation EDGAR Online |
| 04:05PM | Oculus Innovative Sciences Reports Record Revenues of $4.5 Million for the Second Quarter of Fiscal 2013 GlobeNewswire |
| 07:07AM | Q2 2013 OCULUS INNOVATIVE SCIENCES INC Earnings Release - After Market Close CCBN |
